CINECA IRIS Institutional Research Information System

MOSCA, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.666
AS - Asia 12.844
EU - Europa 7.321
SA - Sud America 2.541
AF - Africa 605
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 10
Totale 46.021
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.045
SG - Singapore 4.111
CN - Cina 3.221
HK - Hong Kong 2.263
IT - Italia 2.114
BR - Brasile 2.075
VN - Vietnam 1.474
SE - Svezia 1.150
DE - Germania 763
BG - Bulgaria 757
GB - Regno Unito 506
FR - Francia 457
CA - Canada 437
TR - Turchia 409
FI - Finlandia 375
RU - Federazione Russa 373
IN - India 295
JP - Giappone 223
CI - Costa d'Avorio 195
AR - Argentina 159
UA - Ucraina 153
KR - Corea 129
BD - Bangladesh 118
AT - Austria 111
NL - Olanda 105
ID - Indonesia 101
MX - Messico 100
SN - Senegal 91
IQ - Iraq 89
EC - Ecuador 76
ES - Italia 73
NG - Nigeria 70
PL - Polonia 70
BE - Belgio 63
ZA - Sudafrica 63
MA - Marocco 56
PK - Pakistan 55
CO - Colombia 53
VE - Venezuela 52
CH - Svizzera 44
SA - Arabia Saudita 44
UZ - Uzbekistan 38
PY - Paraguay 37
MY - Malesia 33
PH - Filippine 31
EG - Egitto 30
PE - Perù 30
CL - Cile 29
KE - Kenya 29
LT - Lituania 27
AU - Australia 26
CZ - Repubblica Ceca 23
GR - Grecia 23
AE - Emirati Arabi Uniti 20
JO - Giordania 20
PT - Portogallo 20
IE - Irlanda 18
UY - Uruguay 18
AL - Albania 17
IL - Israele 16
KZ - Kazakistan 16
OM - Oman 16
RS - Serbia 16
TH - Thailandia 16
NP - Nepal 15
TN - Tunisia 15
AZ - Azerbaigian 14
DZ - Algeria 14
CR - Costa Rica 12
IR - Iran 12
ET - Etiopia 11
BJ - Benin 10
BO - Bolivia 10
DO - Repubblica Dominicana 10
JM - Giamaica 10
RO - Romania 10
TT - Trinidad e Tobago 10
DK - Danimarca 9
TW - Taiwan 9
NZ - Nuova Zelanda 8
PA - Panama 8
BY - Bielorussia 7
HN - Honduras 7
LB - Libano 7
EU - Europa 6
BH - Bahrain 5
GE - Georgia 5
HR - Croazia 5
KG - Kirghizistan 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CY - Cipro 4
GT - Guatemala 4
KW - Kuwait 4
LY - Libia 4
PS - Palestinian Territory 4
SI - Slovenia 4
Totale 45.948
Salva come PNG Salva come JPEG
Città #
Ashburn 2.525
Singapore 2.295
Hong Kong 2.233
Fairfield 1.855
Woodbridge 1.840
Houston 1.320
Dallas 1.295
Ann Arbor 1.225
Santa Clara 1.201
San Jose 1.147
Chandler 1.136
Shanghai 968
Seattle 798
Sofia 752
New York 623
Cambridge 620
Beijing 600
Wilmington 594
Milan 485
Boardman 465
Ho Chi Minh City 431
Los Angeles 337
Ottawa 320
Princeton 316
Lawrence 301
Hanoi 291
Lauterbourg 281
Medford 258
Munich 236
Hefei 211
Tokyo 199
Abidjan 195
Serra 191
Des Moines 188
Izmir 186
Boulder 174
London 173
Florence 164
Nanjing 164
São Paulo 161
Istanbul 154
Redondo Beach 147
Jacksonville 138
Frankfurt am Main 137
Council Bluffs 127
San Diego 126
Seoul 123
Dong Ket 119
Pisa 119
Buffalo 118
Dearborn 116
Turku 103
Dakar 91
Helsinki 88
Bremen 82
Rome 81
Ogden 75
Redwood City 72
Nuremberg 71
Vienna 71
Lancaster 62
Lagos 61
Brussels 56
Da Nang 56
Falls Church 56
Nanchang 55
Columbus 53
Rio de Janeiro 53
Livorno 50
Pune 50
Belo Horizonte 49
Haiphong 49
Warsaw 45
Chicago 43
Kunming 43
Shenyang 43
Changsha 42
Curitiba 41
The Dalles 41
Fuzhou 40
Norwalk 40
Baghdad 39
Guangzhou 39
Porto Alegre 39
Orem 38
Montreal 36
Tashkent 36
Brasília 35
Bern 34
Brooklyn 34
Chennai 34
Hebei 34
Mumbai 31
Quito 31
San Francisco 31
Campinas 30
Denver 30
Düsseldorf 30
Phoenix 29
Thái Bình 29
Totale 32.579
Salva come PNG Salva come JPEG
Nome #
Treat-to-target in systemic lupus erythematosus: where are we today? 259
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force 242
Leukopenia, lymphopenia, andneutropenia in systemic lupus erythematosus: Prevalence and clinical impact--A systematic literature review 239
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 234
Depression and systemic lupus erythematosus: a systematic review 225
Insomnia symptoms, perceived stress and coping strategies in patients with systemic lupus erythematosus 210
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 204
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome 202
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 198
Low FODMAP diet: Evidence, doubts, and hopes 189
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 187
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 183
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 181
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 181
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 179
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. 179
null 179
Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus 178
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 178
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein 176
Assessment of disease activity in systemic lupus erythematosus. 174
Mixed connective tissue disease. 174
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. 174
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 174
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 172
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 171
The role of imaging in the evaluation of joint involvement in 102 consecutive patients with systemic lupus erythematosus 170
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature 170
Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. 169
Undifferentiated connective tissue diseases (UCTD) 168
Epidemiology and Management of Neuropsychiatric Disorders in Behçet's Syndrome. 168
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 167
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy 166
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 166
Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus 165
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 164
Vascular reactivity in patients with undifferentiated connective tissue diseases 164
Personalization of biologic therapy in patients with rheumatoid arthritis: Less frequently accounted choice-driving variables 164
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity 162
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 161
Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases 159
Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. 159
The association of Sjögren syndrome and autoimmune thyroid disorders 159
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 159
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 159
Comparison of different forms of Raynaud's phenomenon by LASCA proximal-distal gradient perfusion 158
Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus 158
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 158
Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association 157
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 157
Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) 157
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 156
Prognostic value of flow mediated dilation in patients with systemic lupus erythematosus: A pilot prospective cohort study. 155
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 155
Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms 153
Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis 153
Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology 152
Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood. 152
Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center 152
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 152
null 151
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 151
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine 151
Undifferentiated connective tissue diseases (UCTD): Simplified systemic autoimmune diseases 150
Risk factors for osteoporosis in female patients with systemic lupus erythematosus 149
Systemic lupus erythematosus one disease or many? 148
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 148
COVID-19: the new challenge for rheumatologists 147
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 146
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study 146
Sjögren's syndrome: state of the art on clinical practice guidelines 146
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 145
Antiphospholipid syndrome: state of the art on clinical practice guidelines 145
Sexual dysfunction in Behçet's syndrome 145
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 144
The impact of skin calcinosis on digital ulcers in patients with SSc: clinical and prognostic stratification using the “wound bed score” 144
Relapsing polychondritis: state of the art on clinical practice guidelines 144
clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen 143
[Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide] 143
The diagnosis and classification of undifferentiated connective tissue diseases. 143
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 142
UCTD and SLE patients show increased levels of oxidative and DNA damage together with an altered kinetics of DSB repair 142
null 141
The economic impact of gout: a systematic literature review. 141
Histopathology of the muscle in rheumatic diseases 141
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. 141
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies 141
Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease. 140
Systemic lupus erythematosus: state of the art on clinical practice guidelines 140
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION? 140
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 139
Multiparametric Skin Assessment in a Monocentric Cohort of Systemic Sclerosis Patients: Is There a Role for Ultra-High Frequency Ultrasound? 139
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. 139
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 139
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 139
Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres 139
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 139
Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience 139
Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients 138
Systemic sclerosis chronic ulcers: preliminary results of treatment with allogenic skin grafting in a cohort of Italian patients 138
Totale 16.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.080
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021465 0 0 0 0 0 0 0 0 0 0 134 331
2021/20223.303 105 154 66 214 608 538 107 161 134 153 208 855
2022/20233.703 523 495 234 325 418 455 54 258 635 23 247 36
2023/20243.117 221 264 302 169 429 598 302 120 66 39 219 388
2024/202511.168 65 409 248 603 864 1.181 1.209 581 1.123 1.516 1.255 2.114
2025/202613.002 856 1.603 1.795 1.680 1.420 1.082 1.938 651 831 1.108 38 0
Totale 46.893